MSH FAQ

3 Total Items

Question Volume 1

I have a few patients who I really think should have low MSH levels given their insomnia and pain levels as well as chronicity of their illnesses, but LabCorp reports theirs as over 35. Are there circumstances that will cause a false elevation?

Answer

I suspect that we will be able to identify other important neuropeptides as the days go on. Years ago, all I knew about was MSH. Now that I know so much more about VIP, and especially use of VIP replacement, the importance of MSH is a bit diminished. As far as chronic pain, I am most interested in the finding of increased gene activation for markers on B cells of CD 21, CD 81, CD19, CD22 and CD5 in our chronic pain patients. When our next set of microRNA data comes back I will be sending validation samples out to NJC but the hypothesis today is that there is an immune basis for chronic pain that involves abnormal activation of B cells. The idea isn’t plausible at first glance but perhaps that means we need to know more what is plausible in this new world of genomics.

Question Volume 3

I have been following your protocols including use of VIP for the past 8 months. The ERMI in my home has been corrected. My Lyme and co]infections have all been treated. My MSH remains low. What can I do?

Answer

Log in with your premium membership access to view the answer to this question.

Question Volume 3

Can you provide an update on the possible availability of MSH?

Answer

Log in with your premium membership access to view the answer to this question.